The Contrarian

Hegseth’s Testosterone Bit Isn’t About Health

PUBLISHED 7/24/2026 by

The Trump administration has gotten rather … hormonal. As someone who cares deeply about the science and politics of all kinds of bodily matters, including and especially hormonal health and treatments, it is a truly bizarre exercise to unpack the latest news.

Last week, the defense secretary took to the airwaves to announce new mandatory screening of testosterone levels for all military members over 30, arguing the need to “optimize performance,” “combat Operator Syndrome” (a physical and behavioral condition uniquely attributed to soldiers who undergo intense training) and “maximize mission readiness.” Anyone deemed testosterone-deficient will be offered hormone therapy, presumably including the 230,000 women in active-duty service — who presumably may seek access to estrogen, progesterone and/or testosterone (hard to say given that women were not mentioned).

But of course, debate over optimal hormonal health is hardly the point. Only the most jacked-up soldiers fulfill Hegseth’s military fever dream — which he has made clear is devoid of women, whom he wants removed from combat roles altogether (he also has continued to block promotions of active-duty female Naval officers). The Trump administration has already banned transgender soldiers, at least based in part on the theory that their hormone treatments (though, in this case, they’d call it gender-affirming care, with a sneer) would be challenging to sustain.

It is not easy for me to put aside Hegseth’s distorted recasting of testosterone. That said, it happens to be true that federal regulatory guidelines for its usage are in need of an update and upgrade. As a menopause advocate, I fight hard for a world in which accessible, affordable hormonal care and treatment is a priority for all.

Feminist Must-Reads: Our Favorite Books, Essays and Multimedia Projects for America at 250

PUBLISHED 7/2/2026 by

We’ve made it to July—another eighth of the Trump administration’s days behind us, halfway through a hell of a long year, and the eve of a long weekend to commemorate the 250th anniversary of the Declaration of Independence.

President Donald Trump’s apparent glee that women were absent from his recent White House UFC Fight was just the shot of inspiration I needed to collect and curate some of the best feminist takes on democracy to carry us through the national holiday.

Four Years After Dobbs, Women’s Healthcare Is a Scarce Resource

PUBLISHED 6/24/2026 by and

This week marks four years since the Supreme Court revoked the federal right to abortion, catapulting the nation into an era of state-sanctioned deprivation of bodily autonomy for American women.

On this anniversary, we write to take stock of one of the underreported outcomes of Dobbs: the growing number of individuals and families for whom access to healthcare is diminishing because of a rise in medical deserts.

It’s common sense—there is no reason for highly mobile professionals to remain in places where they find themselves increasingly facing the prospect of personal risk for practicing medicine.

Not surprisingly, medical deserts are prevalent in conservative and rural states; the downstream pressure suggests it soon will become an issue for blue states, too.

The impact on America’s unconscionable maternal and infant mortality rates cannot be overstated. The United States has the highest maternal mortality rate of any wealthy country; as rates continue to drop worldwide, they climb higher here, with Black women more than three times more likely than white women to die in childbirth. Infant mortality has risen specifically in states that enacted abortion restrictions since 2022, again with impacts worse among Black infants.

America’s Medical Research System Has Been Failing Women for Generations

PUBLISHED 6/11/2026 by and

For decades, women have been systematically excluded, overlooked and underfunded by America’s scientific and medical institutions—and the consequences are measurable. Women were not required to be included in federally funded clinical research until 1993, and even today, no more than 8.8 percent of NIH grant spending goes toward women’s health research. The result is a dangerous knowledge gap that affects everything from cardiovascular disease and autoimmune disorders to drug safety, maternal health and reproductive care.

The problem transcends partisan politics. While the Trump administration’s cuts to women’s health research have intensified concerns, Democratic and Republican administrations alike have failed to prioritize women’s health.

Private philanthropy and venture capital have also fallen short, with women’s health receiving just a fraction of available funding.

As women face rising healthcare deserts, worsening maternal mortality rates and persistent gaps in diagnosis and treatment, meaningful progress will require action on every front—from federal investment and philanthropy to innovative new funding models focused specifically on women’s health research.

After Years of Delays, E. Jean Carroll Is Finally Paid

PUBLISHED 6/5/2026 by | UPDATED 8/3/2026 at 1:57 P.M. PT

President Donald Trump has paid writer E. Jean Carroll $5.6 million after exhausting his appeals in the civil case in which a federal jury found him liable for sexually abusing and defaming her. The payment, which includes interest and had been held in escrow during the appeals process, was released after the Supreme Court declined to hear Trump’s final appeal and a federal judge ordered the funds disbursed. A separate $83.3 million defamation judgment against Trump in a different Carroll case remains under appeal.

Three Ways Trump’s Weird Fixation on DEI Is Hurting Women

PUBLISHED 5/28/2026 by

The Trump administration’s obsession with diversity, equity and inclusion has moved far beyond rhetoric. It is now reshaping how women’s stories get told, whose health crises are allowed to be named, and what kinds of research are permitted to survive.

Across history, healthcare and science, women are watching decades of hard-fought progress become collateral damage in a culture war designed to erase people in real time.

That damage is already visible.

Republicans derailed long-awaited progress on the American Women’s History Museum by inserting provisions policing which women count as women and handing Trump appointees sweeping control over the museum itself.

Meanwhile, the newly reintroduced Momnibus legislation—created in response to the maternal mortality crisis devastating Black women and families—has been forced to strip much of the word “Black” from its language in order to survive politically under an administration openly hostile to DEI initiatives.

And the consequences are not abstract: NIH grants focused on women’s health have reportedly dropped by 30 percent, while words like “women” and “gender” themselves are becoming liabilities in funding proposals.

Women’s health was already chronically underfunded and misunderstood long before Trump returned to office. But the administration’s escalating war on DEI is accelerating that neglect—and making clear just how much is at stake when political ideology begins dictating whose lives deserve to be studied, protected and remembered.

Where to Watch ‘Ask E. Jean,’ a New Documentary on the Wit, Fury and Fearlessness of E. Jean Carroll

PUBLISHED 5/23/2026 by | UPDATED 6/30/2026 at 10:15 A.M. PT

E. Jean Carroll—the colorful author and advice columnist who beat Donald Trump in court twice—is finally getting the documentary treatment in Ask E. Jean, a film that is as poignant as it is entertaining.

Director Ivy Meeropol first reached out to Carroll after reading the devastating yet vibrant New York Magazine piece in which Carroll accused Trump of raping her in a Bergdorf Goodman dressing room decades earlier.

Carroll’s initial response: “I’d rather eat my shoe.”

But Meeropol persisted, eventually convincing Carroll she wanted to tell the fuller story of her life—not just the trials, but her remarkable rise during the heyday of glossy magazines and New York media culture.

The resulting film traces Carroll’s evolution from Indiana cheerleader to professionally fabulous Manhattan raconteur, weaving together archival footage, legal depositions and deeply personal interviews.

Some of the documentary’s most powerful moments come from previously unseen deposition footage, where Carroll recounts the 1996 assault while enduring invasive questioning from Trump attorney Alina Habba. Even in those moments, Carroll remains irrepressibly funny.

Meeropol says the footage reveals “what really happens when someone who’s brought a charge of rape or sexual abuse is deposed,” while also exposing the broader misogyny women confront “from the minute we’re born.”

Meeropol also describes struggling against “The Trump Effect”—fear within the entertainment industry about supporting projects that could provoke retaliation from Trump or his allies. Distributors hesitated, some producers reportedly asked not to be credited, and the film was repeatedly stalled despite strong festival reviews.

But Ask E. Jean is now expanding into theaters nationwide, bringing Carroll’s story to audiences at a moment when the politics of gender, power and public accountability remain impossible to ignore.

Women’s Health Is a Democracy Issue—and a Midterm One

PUBLISHED 5/21/2026 by

It is critically important to keep reproductive health and the chaos at the Food and Drug Administration (FDA) front and center in the headlines. Why? Two words: midterm elections.

Last week, within 48 hours of each other the Supreme Court issued an emergency stay pausing the Fifth Circuit’s attempt to let Louisiana negate the FDA rule that allows telehealth provision and mail delivery of mifepristone, and FDA commissioner Marty Makary announced his immediate resignation after rumors that President Trump was planning to fire him.

Though Makary’s antipathy toward deregulation of flavored vapes appears to have triggered his fall from grace, and the rest of the chaos is perhaps business as usual, the Trump administration’s tip-toe approach to mifepristone is the real story.

The Justice Department’s litigation approach seemingly has been to wait until October when the FDA’s so-called “safety review” is due—ordered despite the mountain of evidence proving mifepristone’s safety and efficacy. But reports indicate that study has not even begun and is mired in data delays caused by the Department of Health and Human Services.

Foot-dragging? Finger-pointing? Old-fashioned incompetence? Who can tell anymore. But it surely hews to Republicans’ favor to keep the entire endeavor out of public sight, given that the vast majority (68 percent) of adults in this country oppose banning mifepristone.

A Government for Big Tobacco and Bigger Families

PUBLISHED 5/14/2026 by | UPDATED 5/17/2026 at 7:40 A.M. PT

The Department of Health and Human Services (HHS) made multiple headlines last week—starting with the apparent implosion of Dr. Marty Makary’s tenure as Food and Drug Administration commissioner. But beneath the chaos lies something more troubling: a federal health apparatus increasingly shaped by antiabortion pressure campaigns, pronatalist messaging and culture-war governance masquerading as public policy.

From the Supreme Court fight over mifepristone access to the Trump administration’s bizarre new moms.gov initiative—complete with links to antiabortion crisis pregnancy centers and rhetoric about Americans being “under-babied”—the week offered a revealing snapshot of where U.S. health policy is headed. Meanwhile, flavored vape approvals for Big Tobacco sailed through the FDA, even as reproductive healthcare access remains under constant attack.

Chaos may be Trump’s currency, but the throughline here is ideology: rewarding conservative allies, policing reproductive autonomy and repackaging motherhood as a nationalist project while offering little meaningful material support to actual families.